Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ASCO 2013 Report – Lambrolizumab immunotherapy shows efficacy in advanced melanoma

Written by | 10 Jun 2013

Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.

ASCO 2013 Report – Sorafenib shows efficacy in advanced differentiated thyroid cancer

Written by | 10 Jun 2013

by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.

Older and younger chronic leukemia patients may need different therapy

Written by | 5 Jun 2013

Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study.

ASH 2012 Report – Investigational agent targets gene signaling pathways to improve response for patients with CLL

Written by | 21 Dec 2012

The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic… read more.

ASCO 2012 Report – Investigational drug shows promise in advanced melanoma, kidney cancer, and NSCLC

Written by | 20 Nov 2012

by Marybeth Burke – The investigational drug BMS-936558 caused tumour shrinkage in up to a quarter of patients with advanced melanoma, kidney and NSCLC cancers,

Leading cancer specialists from Europe and beyond recognized at ESMO 2012

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to… read more.

ESMO 2011 Report – Shaping the future: from principle to practice

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – One of the most important advances in cancer research over the last decade or so has been the appearance of targeted therapies. It… read more.

Genital herpes can reactivate even during high dose antiviral therapy

Written by | 16 Mar 2012

Taken from The Lancet – by Bruce Sylvester – A new evaluation of data from three trials of antiviral therapy to treat genital herpes (herpes simplex virus type… read more.

IASLC 2011 Report – Emerging immunotherapies in the management of lung cancer

Written by | 18 Jan 2012

by Dr Sunil Upadhyay – Advanced non-small cell carcinoma of the lung represents one of the major unmet needs for an effective and prolonged survival outcome. The majority… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.